- Home
- GMM vs YI Comparison
GMM vs YI Comparison
Compare GMM & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GMM | YI |
|---|---|---|
| Founded | 2017 | 2010 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | | Retail-Drug Stores and Proprietary Stores |
| Sector | | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.4M | 38.1M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | GMM | YI |
|---|---|---|
| Price | $1.28 | $3.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 15.8K | 11.5K |
| Earning Date | 08-18-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.79 | N/A |
| Revenue | $48,171,048.00 | ★ $1,979,883,442.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.75 | ★ N/A |
| Revenue Growth | ★ 41.74 | N/A |
| 52 Week Low | $1.23 | $3.19 |
| 52 Week High | $4.97 | $11.35 |
Technical Indicators
Market Signals| Indicator | GMM | YI |
|---|---|---|
| Relative Strength Index (RSI) | 30.01 | 40.75 |
| Support Level | $1.25 | $3.60 |
| Resistance Level | $1.59 | $3.88 |
| Average True Range (ATR) | 0.09 | 0.19 |
| MACD | -0.02 | 0.04 |
| Stochastic Oscillator | 28.21 | 69.51 |
Price Performance
Historical ComparisonAbout GMM Global Mofy Metaverse Limited
Global Mofy AI Ltd operates as a technology solutions provider engaged in virtual content production, digital marketing, and digital assets development for the metaverse industry. It utilizes its proprietary Mofy Lab technology platform which consists of three-dimensional (3D) rebuilt technology and artificial intelligence (AI) interactive technology to create a 3D high-definition virtual version of a wide range of physical world objects such as human, animal, and scenes which can be used in different applications.
About YI 111 Inc.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.